Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine in ESP Block for Laparoscopic Cholecystectomy
NCT05369468Phase 2Completed
- Sponsor
- Tanta University
- Start
- Jan 2020
- Primary completion
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of dexmedetomidine in postoperative pain (2 arms), sponsored by Tanta University. Primary endpoint: Total amount of morphine consumption in the first 24-hour postoperative. Started Jan 2020; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05369468.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05369468.